Rare diseases
Investigational molecules
Locations
Back to Italy213 clinical trials in Aviano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer
ItalyStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
ItalyStudy on Chlorambucil and Rituximab for Patients with MALT Lymphoma
ItalyStudy on the Safety and Effectiveness of Fianlimab, Cemiplimab, and Chemotherapy in Adults with Resectable Non-Small Cell Lung Cancer
ItalyStudy of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
ItalyStudy of Atezolizumab and Drug Combination for Patients with Relapsed or Refractory Hodgkin's Lymphoma Eligible for Stem Cell Transplant
ItalyStudy on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment
ItalyStudy of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy
ItalyStudy on Prednisone and Vitamin D for Elderly Patients with Diffuse Large B-Cell Lymphoma
ItalyStudy on Carboplatin, Paclitaxel, Bevacizumab, and Rucaparib for Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Patients
ItalyStudy Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments
ItalyStudy of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring new treatment combinations for non-small cell lung cancer (NSCLC), including studies of novel immunotherapy approaches and targeted therapies. Research focuses on improving outcomes for patients with advanced stages of the disease.
Clinical investigations targeting hormone receptor-positive and triple-negative breast cancers, evaluating novel therapeutic combinations and treatment strategies for both early-stage and metastatic disease.
Research examining innovative approaches for metastatic colorectal cancer, including studies of targeted therapies and immunotherapy combinations. Focus on personalized treatment strategies based on molecular profiles.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
